However, mice harboring the LAG3 K27E mutation, which abolishes FGL1 binding without affecting MHC binding, did not experience exacerbation of T1D, implying that FGL1 is not required for LAG3-mediated mitigation of autoimmunity, at least in the NOD model. This evidence concerns the gene LAG3 and type 1 diabetes mellitus.